MUMBAI Nov 20 Indian drugmaker Lupin Ltd said on Tuesday it launched a generic version of Abbott Laboratories' cholesterol lowering drug TriCor in the United States.
Lupin got its generic fenofibrate drug approved by the U.S. Food and Drug Administration last December.
Tricor tablets have annual sales of $1.26 billion in the United States, Lupin said in a statement.
Valued $4.46 billion, shares in Lupin closed 1.11 percent up at 568.15 rupees on Tuesday, when the Mumbai stock market was almost flat.
FOREX-Dollar wobbles vs yen and euro, U.S. presidential debate awaited
* USD off lows but wobbly as market braces for political events
PRESS DIGEST- British Business - Sept 26
Sept 26 The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy.